Zobrazeno 1 - 4
of 4
pro vyhledávání: '"CLADRIBINE – therapeutic use"'
Autor:
Per Soelberg Sorensen, Luigi Pontieri, Hanna Joensen, Alex Heick, Peter Vestergaard Rasmussen, Jakob Schäfer, Rikke Ratzer, Caroline Ellinore Pihl, Finn Sellebjerg, Melinda Magyari
Publikováno v:
Sorensen, P S, Pontieri, L, Joensen, H, Heick, A, Rasmussen, P V, Schäfer, J, Ratzer, R, Pihl, C E, Sellebjerg, F & Magyari, M 2023, ' Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis : A Danish nationwide study ', Multiple Sclerosis and Related Disorders, vol. 70, 104491 . https://doi.org/10.1016/j.msard.2022.104491
BACKGROUND: Cladribine is a nucleoside analogue interfering with synthesis and repair of DNA. Treatment with cladribine leads to a preferential reduction in lymphocytes, resulting in profound depletion of B-cells with a rapid recovery of naïve B-cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce0c113b0169309b5c87eec38d5c5b3
https://vbn.aau.dk/ws/files/514548645/S_rensen_et_al._2022_Real_world_experience_of_cladribine_treatment_in_relapsing_remitting_multiple_sclerosis.pdf
https://vbn.aau.dk/ws/files/514548645/S_rensen_et_al._2022_Real_world_experience_of_cladribine_treatment_in_relapsing_remitting_multiple_sclerosis.pdf
Autor:
Krečak, Ivan, Rončević, Pavle, Kursar, Marin, Lucijanić, Marko, Galušić, Davor, Mrđenović, Stefan, Morić Perić, Martina, Ivanko, Iva, Matijaca, Hana, Budimir, Josipa, Jakelić, Sanja, Karaman, Ivana, Kušec, Rajko
Publikováno v:
Liječnički vjesnik
Volume 144
Issue 9-10
Volume 144
Issue 9-10
Cilj: Ciljevi ove studije bili su identificirati bolesnike sa sistemskom mastocitozom (SM) u Republici Hrvatskoj (RH) i analizirati njihove kliničke karakteristike. ----- Ispitanici i metode: Retrospektivno su iz osam hematoloških centara u RH iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bc6a527276862a4e8a3978a487d9c0bb
https://doi.org/10.26800/lv-144-9-10-3
https://doi.org/10.26800/lv-144-9-10-3
Publikováno v:
Orphanet journal of rare diseases
Orphanet journal of rare diseases, 2014, 9, pp.191. ⟨10.1186/s13023-014-0191-8⟩
Orphanet Journal of Rare Diseases (9), 1-8. (2014)
Orphanet Journal of Rare Diseases, vol. 9, no. 1, pp. 191
Orphanet Journal of Rare Diseases
Orphanet journal of rare diseases, 2014, 9, pp.191. ⟨10.1186/s13023-014-0191-8⟩
Orphanet Journal of Rare Diseases (9), 1-8. (2014)
Orphanet Journal of Rare Diseases, vol. 9, no. 1, pp. 191
Orphanet Journal of Rare Diseases
International audience; BACKGROUND: Pulmonary Langerhans cell histiocytosis (PLCH) is a rare disorder characterised by granulomatous proliferation of CD1a-positive histiocytes forming granulomas within lung parenchyma, in strong association with toba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39ceee6d135e6f4c820a1085a23056c
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02192909
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02192909
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.